Time-dependent Cox regression: Serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection

International Journal of Cardiology

Volumn 161, Issue 3, 2012, Pages 166-173

  Hartmann, Oliver ^a   Schuetz, Philipp ^b   Albrich, Werner C ^b   Anker, Stefan D ^c,e   Mueller, Beat ^b   Schmidt, Thorsten ^d  

^a THERMO FISHER SCIENTIFIC   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CHEMNITZ UNIVERSITY OF TECHNOLOGY   (Germany)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cardiovascular biomarker; Serial measurements; Time dependent Cox regression

Indexed keywords

BIOLOGICAL MARKER; PROADRENOMEDULLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSPNEA; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL;

ADRENOMEDULLIN; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTIONS; SURVIVAL RATE; TIME FACTORS;

EID: 84869497234     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.014     Document Type: Article

References (35)

1. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, and A.S. Jaffe Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure J Am Coll Cardiol 54 18 Oct 27 2009 1715 1721
2. W.L. Miller, K.A. Hartman, and M.F. Burritt Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 3 Jul 17 2007 249 257
3. D. Logeart, G. Thabut, and P. Jourdain Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 4 Feb 18 2004 635 641
4. R. Latini, S. Masson, and M. Wong Incremental prognostic value of changes in B-type natriuretic peptide in heart failure Am J Med 119 1 Jan 2006 70.e23 70.e30
5. S. Masson, R. Latini, and I.S. Anand Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 12 Sep 16 2008 997 1003
6. D. Moertl, A. Hammer, M. Huelsmann, R. Pacher, and R. Berger Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients Eur J Heart Fail 10 4 Apr 2008 404 411
7. Y. Xue, J. Chan, S. Sakariya, and A. Maisel Biomarker-guided treatment of congestive heart failure Congest Heart Fail 16 Suppl. 1 Jul 2010 S62 S67
8. A. Maisel, C. Mueller, and R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 19 May 11 2010 2062 2076
9. A.A. Voors, S. von Haehling, and S.D. Anker C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study Eur Heart J 30 10 May 2009 1187 1194
10. M. Katan, F. Fluri, and N.G. Morgenthaler Copeptin: a novel, independent prognostic marker in patients with ischemic stroke Ann Neurol 66 6 Dec 2009 799 808
11. P. Schuetz, M. Wolbers, and M. Christ-Crain Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 14 3 2010 R106
12. O.S. Dhillon, S.Q. Khan, and H.K. Narayan Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study J Am Coll Cardiol 56 2 Jul 6 2010 125 133
13. J. Struck, C. Tao, N.G. Morgenthaler, and A. Bergmann Identification of an adrenomedullin precursor fragment in plasma of sepsis patients Peptides 25 2004 1369 1372
14. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin. Chem. 51 2005 1823 1829
15. P. Caruhel, C. Mazier, J. Kunde, N.G. Morgenthaler, and B. Darbouret Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S. KRYPTOR Clin. Biochem. 42 2009 725 728
16. A. Maisel, C. Mueller, and R.M. Nowak Mid-region prohormone adrenomedulin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in ACute Heart failure) trial J Am Coll Cardiol 58 10 Aug 30 2011 1057 1067
17. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model Statistics for Biology and Health 2000 Springer-Verlag New York
18. F.E. Harrell Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 Springer-Verlag New York
19. C. Proust-Lima, and J.M. Taylor Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach Biostatistics 10 3 Jul 2009 535 549
20. R. Henderson, P. Diggle, and A. Dobson Identification and efficacy of longitudinal markers for survival Biostatistics 3 1 Mar 2002 33 50
21. Y.H. Sparling, N. Younes, J.M. Lachin, and O.M. Bautista Parametric survival models for interval-censored data with time-dependent covariates Biostatistics 7 4 Oct 2006 599 614
22. A.J.S. Coats, and L.G. Shewan Statement on authorship and publishing ethics in the International Journal of Cardiology Int J Cardiol 153 2011 239 240
23. P. Schuetz, M. Christ-Crain, and M. Wolbers Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC Health Serv Res 7 Jul 5 2007 102
24. P. Schuetz, M. Christ-Crain, and R. Thomann Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial J Am Med Assoc 302 10 Sep 9 2009 1059 1066
25. J.D. Kalbfleisch, and R.L. Prentice The statistical analysis of failure time data 2nd edition Wiley Series in Probability and Statistics 2002 Wiley-Interscience [John Wiley & Sons] Hoboken, NJ
26. J.P. Klein, and M.L. Moeschberger Survival Analysis: Techniques for Censored and Truncated Data Statistics for Biology and Health 2003 Springer-Verlag New York
27. G. Heinze, and D. Dunkler Avoiding infinite estimates of time-dependent effects in small-sample survival studies Stat Med 27 2008 6455 6469
28. R.D. Gill Understanding Cox's regression model: a martingale approach J Am Stat Assoc 79 1984 441 447
29. B. Mueller, S. De Geest, W.C. Albrich, and B. Reutlinger Calcitonin gene derived peptides for an Optimized Patient Transfer using an Innovative Multidisciplinary Assessment in the Canton Aargau (OPTIMA II) ISRCTN62022490 http://www.controlled-trials.com
30. W.C. Albrich, K. Rueegger, and F. Dusemund Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I) - an observational survey in lower respiratory tract infections Swiss Med Wkly 141 2011 w13237
31. R.J. Cook, L. Zeng, and G.Y. Yi Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation Biometrics 60 3 Sep 2004 820 828
32. S. Halabi, C.C. Wun, and B.R. Davis Analysis of survival data with missing measurements of a time-dependent binary covariate J Biopharm Stat 13 2 May 2003 253 270
33. R. Schoop, E. Graf, and M. Schumacher Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates Biometrics 64 2 Jun 2008 603 610
34. Y. Zheng, and P.J. Heagerty Prospective accuracy for longitudinal markers Biometrics 63 2 Jun 2007 332 341
35. C. Proust-Lima, and J.M. Taylor Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach Biostatistics 10 3 Jul 2009 535 549